STOCK TITAN

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

ANI Pharmaceuticals (ANIP) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 14, 2025, at 2:15pm PST/5:15pm EST in San Francisco. Key executives presenting include President and CEO Nikhil Lalwani, CFO Stephen Carey, and CMO Dr. Mary Pao.

The presentation will be available via live webcast and can be accessed through the company's website at www.anipharmaceuticals.com under the Investors section's Events and Presentations area. An archived version of the webcast will remain accessible for 90 days following the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+1.97% News Effect

On the day this news was published, ANIP gained 1.97%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PRINCETON, N.J., Dec. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer; Stephen Carey, Chief Financial Officer; and Dr. Mary Pao, Chief Medical Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 2:15pm PST/5:15pm EST, in San Francisco.

The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.


FAQ

When is ANI Pharmaceuticals (ANIP) presenting at the J.P. Morgan Healthcare Conference 2025?

ANI Pharmaceuticals will present on Tuesday, January 14, 2025, at 2:15pm PST/5:15pm EST in San Francisco.

How can investors watch ANI Pharmaceuticals' J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via live webcast on ANI Pharmaceuticals' website (www.anipharmaceuticals.com) under the Investors section's Events and Presentations area.

How long will the replay of ANIP's J.P. Morgan Healthcare Conference presentation be available?

The webcast replay will be accessible for 90 days following the presentation.

Which executives from ANI Pharmaceuticals will present at the 2025 J.P. Morgan Healthcare Conference?

Nikhil Lalwani (President and CEO), Stephen Carey (CFO), and Dr. Mary Pao (CMO) will present at the conference.
Ani Pharmaceutic

NASDAQ:ANIP

ANIP Rankings

ANIP Latest News

ANIP Latest SEC Filings

ANIP Stock Data

1.71B
19.14M
10.42%
97.8%
9.42%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
BAUDETTE